caosCan Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels.
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs Ezetimibe (Primary) ; Herbal medicines; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 13 Aug 2012 Planned end date changed from 1 Aug 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 15 Mar 2011 Planned end date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.